These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4259384)

  • 1. Immune response to hepaitis virus type B in Down's syndrome and other mentally retarded patients.
    Hollinger FB; Goyal RK; Hersh T; Powell HC; Schulman RJ; Malnick JL
    Am J Epidemiol; 1972 Apr; 95(4):356-62. PubMed ID: 4259384
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of hepatitis B virus in an institution for mentally retarded persons.
    Madden DL; Dietzman DE; Matthew EB; Sever JL; Lander JJ; Purcell RH; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):369-75. PubMed ID: 129004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and distribution of hemagglutinating antibody against the hepatitis B antigen in institutionalized populations.
    Szmuness W; Prince AM; Etling GF; Pick R
    J Infect Dis; 1972 Nov; 126(5):498-506. PubMed ID: 4268554
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of Australia antigen in patients with Down's syndrome in Poland.
    Zdzienicka E; Kacperska E
    J Ment Defic Res; 1971 Mar; 15(1):30-7. PubMed ID: 4253115
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Shiono H; Kadowaki J; Fujiwara T; Nakao T
    Clin Pediatr (Phila); 1975 Dec; 14(12):1150-4. PubMed ID: 127683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to hepatitis B vaccine in the mentally retarded.
    Wahl M; Hermodsson S; Iwarson S
    J Infect; 1983 Jul; 7 Suppl 1():47-51. PubMed ID: 6232324
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID; Dimitrakakis M; Sharma DL
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid antibodies and Australia antigen in Down's syndrome.
    Fialkow PJ; Blumberg BS; London WT; Sutnick AI; Thuline HC
    J Ment Defic Res; 1971 Sep; 15(3):177-80. PubMed ID: 4255524
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in Down's syndrome. I. Genetic predisposition to become a carrier of the Au-SH antigen?
    Rittner C; Schwinger E; Stockhausen FG; Dufkova J
    Vox Sang; 1970; 19(3):280-7. PubMed ID: 4251110
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of antibody to the hepatitis A virus in a large institution for the mentally retarded.
    Lehmann NI; Sharma DL; Gust ID
    J Med Virol; 1978; 2(4):335-9. PubMed ID: 215714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australia antigen, autoantibodies and cell-mediated immune responses in patients with Down's syndrome.
    Campion EC; Wangel AG
    Med J Aust; 1975 Apr; 01(15):468-70. PubMed ID: 125374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of serotypes of hepatitis B surface antigen in an institution for the mentally retarded.
    Madden DL; Dietzman DE; Matthew EB; Fuccillo DA; Hall WT; Bond HE; Rostafinski M
    J Infect Dis; 1975 Apr; 131(4):439-42. PubMed ID: 123264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal hepatitis B vaccination for mentally retarded patients.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W
    J Infect; 1989 Sep; 19(2):119-25. PubMed ID: 2530288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK; Perry E; Cleary TE
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australia antigen and Down's syndrome.
    Shapiro LR; Redner WJ; Innella FP
    Lancet; 1971 Jul; 2(7717):215-6. PubMed ID: 4104877
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic reactions and Australia antigenemia in Down's syndrome.
    Hollingsworth DR; Hollingsworth JW; Roeckel I; McKean HE; Holland N
    J Chronic Dis; 1974 Nov; 27(9-10):483-90. PubMed ID: 4139169
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ; de Witte-van der Schoot E; van Loon AM; Rijntjes PJ; Yap SH
    Am J Epidemiol; 1988 Sep; 128(3):629-38. PubMed ID: 2970793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B (HBV) and C (HBC) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome].
    Findor JA; Sordá JA; Rey J; Fernández J; Kohan A; Díaz Lestrem M
    G E N; 1992; 46(3):208-12. PubMed ID: 1340826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.